Vertex Pharmaceuticals (VRTX) Fails to deliver data

Key failure to deliver metrics for Vertex Pharmaceuticals:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: £17.69 M
• Last 3 months FTD volume: £20.22 M
• Last year FTD volume: £20.22 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013

Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	£29.33 M	£0.23 B	🇺🇸 USA
AbbVie ABBV	£75.4 M	£0.15 B	🇺🇸 USA
Merck MRK	£14.45 M	£88.44 M	🇺🇸 USA
Bristol-Myers Squibb BMY	£29.95 M	£0.31 B	🇺🇸 USA
Johnson & Johnson JNJ	£70.18 M	£0.32 B	🇺🇸 USA
Enanta Pharmaceuticals ENTA	£0 M	£0.35 M	🇺🇸 USA